New Delhi, April 15 (IANS) Healthcare companies in India are expected to deliver high single-digit revenue growth (year-on-year) in the fourth quarter of FY26 (Q4 FY26), a report showed on Wednesday.However, EBITDA margins will materially be corrected, according to the report by Systematix.“Median growth is estimated at 12 per cent for revenue and 3.6 per cent for EBTIDA, with net earnings likely witnessing a 14 per cent decline, the report mentioned.The primary driver of this on-year decline …
Latest Dr. Reddy’s News & Updates
Mumbai, April 7 (IANS) The Indian stock markets on Tuesday witnessed sharp losses in early trade, with equity benchmarks declining 1 per cent each amid uncertainty over a possible resolution to the West Asia conflict, ahead of a deadline set by US President Donald Trump to reopen the Strait of Hormuz.Sensex opened 372 points or 0.50 per cent lower at 73,734, while Nifty began the session at 22,838.Later in early trade, the 30-scrip basket declined as much as 1.11 per cent or 824.44 points, hitti…
New Delhi, Dec 26 (IANS) From changing the definition to the rise of GLP-1 medications, and the government’s several initiatives, especially Prime Minister Narendra Modi’s clarion call, obesity became the focus of healthcare in India in 2025.The anti-obesity drive, especially the generic drugs, will continue to remain a key focus in 2026.Traditionally, Body Mass Index (BMI) was used to define obesity, but after 15 long years, India revamped its obesity guidelines in 2025 by lowering the thresh…